Despite the share price decline, TECON BIOLOGYLTD's solid re...
Despite the share price decline, TECON BIOLOGYLTD's solid revenue growth could indicate a brighter future. However, the company's performance needs to substantially improve to reverse the negative trend in its share price.
TECON BIOLOGYLTD (SZSE:002100 Investor Three-year Losses Grow to 29% as the Stock Sheds CN¥478m This Past Week
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment